These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 8831110)
1. Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum. Sim LJ; Selley DE; Xiao R; Childers SR Eur J Pharmacol; 1996 Jun; 307(1):97-105. PubMed ID: 8831110 [TBL] [Abstract][Full Text] [Related]
2. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding. Sim LJ; Selley DE; Childers SR Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7242-6. PubMed ID: 7638174 [TBL] [Abstract][Full Text] [Related]
3. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain. Sim LJ; Childers SR J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852 [TBL] [Abstract][Full Text] [Related]
4. mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Selley DE; Sim LJ; Xiao R; Liu Q; Childers SR Mol Pharmacol; 1997 Jan; 51(1):87-96. PubMed ID: 9016350 [TBL] [Abstract][Full Text] [Related]
5. Autoradiographic distribution of mu-, delta- and kappa 1-opioid stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in human frontal cortex and cerebellum. Platzer S; Winkler A; Schadrack J; Dworzak D; Tölle TR; Zieglgänsberger W; Spanagel R Neurosci Lett; 2000 Apr; 283(3):213-6. PubMed ID: 10754225 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes. Selley DE; Stark S; Sim LJ; Childers SR Life Sci; 1996; 59(8):659-68. PubMed ID: 8761016 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol. Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037 [TBL] [Abstract][Full Text] [Related]
8. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes. Breivogel CS; Selley DE; Childers SR J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416 [TBL] [Abstract][Full Text] [Related]
10. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen. Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241 [TBL] [Abstract][Full Text] [Related]
11. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Traynor JR; Nahorski SR Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747 [TBL] [Abstract][Full Text] [Related]
12. Mu and delta opioid-stimulated [35S]GTP gamma S binding in brain and spinal cord of polyarthritic rats. Cichewicz DL; Cox ML; Welch SP; Selley DE; Sim-Selley LJ Eur J Pharmacol; 2004 Nov; 504(1-2):33-8. PubMed ID: 15507218 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes. Griffin G; Atkinson PJ; Showalter VM; Martin BR; Abood ME J Pharmacol Exp Ther; 1998 May; 285(2):553-60. PubMed ID: 9580597 [TBL] [Abstract][Full Text] [Related]
14. Region-dependent G-protein activation by mu-, delta 1- and delta 2-opioid receptor agonists in the brain: comparison between the midbrain and forebrain. Tsuji M; Narita M; Mizoguchi H; Narita M; Ohsawa M; Kamei J; Nagase H; Takeda H; Matsumiya T; Tseng LF Life Sci; 1999; 65(16):PL233-9. PubMed ID: 10573190 [TBL] [Abstract][Full Text] [Related]
15. Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors. Shapira M; Vogel Z; Sarne Y Cell Mol Neurobiol; 2000 Jun; 20(3):291-304. PubMed ID: 10789829 [TBL] [Abstract][Full Text] [Related]
16. Mu and kappa1 opioid-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain. Sim-Selley LJ; Daunais JB; Porrino LJ; Childers SR Neuroscience; 1999; 94(2):651-62. PubMed ID: 10579225 [TBL] [Abstract][Full Text] [Related]
17. Effects of neonatal cocaine treatment and gender on opioid agonist-stimulated [(35)S]GTP gamma S binding in the striatum and nucleus accumbens. Meyer JS; Shani I; Rice D Brain Res Bull; 2000 Sep; 53(2):147-52. PubMed ID: 11044590 [TBL] [Abstract][Full Text] [Related]
18. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus. Selley DE; Liu Q; Childers SR J Pharmacol Exp Ther; 1998 May; 285(2):496-505. PubMed ID: 9580589 [TBL] [Abstract][Full Text] [Related]
19. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor. Zhang D; Li JG; Chen C; Liu-Chen LY Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435 [TBL] [Abstract][Full Text] [Related]
20. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain. Saland LC; Abeyta A; Frausto S; Raymond-Stintz M; Hastings CM; Carta M; Valenzuela CF; Savage DD Alcohol Clin Exp Res; 2004 Jan; 28(1):98-104. PubMed ID: 14745307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]